IRIS Accounts Production v24.3.0.553 06829318 Board of Directors 1.3.23 29.2.24 29.2.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh068293182023-02-28068293182024-02-29068293182023-03-012024-02-29068293182022-02-28068293182022-03-012023-02-28068293182023-02-2806829318ns15:EnglandWales2023-03-012024-02-2906829318ns14:PoundSterling2023-03-012024-02-2906829318ns10:Director12023-03-012024-02-2906829318ns10:PrivateLimitedCompanyLtd2023-03-012024-02-2906829318ns10:Micro-entities2023-03-012024-02-2906829318ns10:AuditExempt-NoAccountantsReport2023-03-012024-02-2906829318ns10:FullAccounts2023-03-012024-02-2906829318ns5:CurrentFinancialInstruments2024-02-2906829318ns5:CurrentFinancialInstruments2023-02-2806829318ns10:RegisteredOffice2023-03-012024-02-29068293181ns10:Director12023-02-28068293181ns10:Director12022-02-28068293181ns10:Director12023-03-012024-02-29068293181ns10:Director12022-03-012023-02-28068293181ns10:Director12024-02-29068293181ns10:Director12023-02-28
REGISTERED NUMBER: 06829318 (England and Wales)















Unaudited Financial Statements for the Year Ended 29th February 2024

for

Cosmetic Surgeons London Ltd

Cosmetic Surgeons London Ltd (Registered number: 06829318)






Contents of the Financial Statements
for the Year Ended 29th February 2024




Page

Balance Sheet 1


Cosmetic Surgeons London Ltd (Registered number: 06829318)

Balance Sheet
29th February 2024

29.2.24 28.2.23
£    £    £    £   
FIXED ASSETS 118,739 3,144

CURRENT ASSETS 1,308,272 1,330,022

CREDITORS
Amounts falling due within one year (60,685 ) (99,299 )
NET CURRENT ASSETS 1,247,587 1,230,723
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,366,326

1,233,867

CAPITAL AND RESERVES 1,366,326 1,233,867

NOTES TO THE FINANCIAL STATEMENTS

1. COMPANY INFORMATION

Cosmetic Surgeons London Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06829318

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .

3. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 29th February 2024 and 28th February 2023:

29.2.24 28.2.23
£    £   
Dr N M Sojitra
Balance outstanding at start of year (852 ) (11,811 )
Amounts advanced 188,416 164,271
Amounts repaid (185,206 ) (153,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,358 (852 )

This loan is repayable on demand and no interest was charged during the year.



Cosmetic Surgeons London Ltd (Registered number: 06829318)

Balance Sheet - continued
29th February 2024


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 29th February 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 29th February 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 25th November 2024 and were signed on its behalf by:





Dr N M Sojitra - Director